Isoeugenol-derived polyphenolic compounds modulate FOLFOX response, drug resistance, migration, and stemness-associated signatures in HT29 colon cancer cells and an HT29-CSC-enriched population
Bioorganic Chemistry · 2026-12 · 185 · 110714
DOI: 10.1016/j.bioorg.2026.110714 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026-12. Verfasst von Sema Bilgin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tokat Gaziosmanpasa University, Tokat, Türkiye. Electronic address: nsema.bilgin@gma…. Die Arbeit nennt 67 Literaturangaben. Gefördert von: TÜBİTAK.
Abstract (Originalsprache)
Chemoresistance, cancer stem cell-associated plasticity, and migratory capacity limit the efficacy of FOLFOX-based chemotherapy in colon cancer. This study investigated the effects of two original isoeugenol-derived polyphenolic compounds, 1 and 2, alone and in combination with FOLFOX, in HT29 colon cancer cells and an HT29-derived cancer stem cell-enriched population. Cell viability was assessed by MTT assay, drug interactions were evaluated using the Chou-Talalay combination index method, wound closure was analyzed by scratch assay, and multidrug resistance-, stemness-, and migration/metastasis-associated gene expression profiles were examined by real-time quantitative polymerase chain reaction. Molecular docking was performed against selected proteins related to drug transport, extracellular matrix remodeling, angiogenesis, and cancer stem cell biology. In HT29 cells, the half-maximal inhibitory concentration (IC₅₀) of FOLFOX decreased from 191.80 μM at 24 h to 15.52 μM at 48 h, while FOLFOX +1 and FOLFOX +2 further reduced the 48-h IC₅₀ values to 13.30 and 14.95 μM, respectively. In the HT29-CSC-enriched population, FOLFOX showed a 48-h IC₅₀ of 26.80 μM, whereas FOLFOX +2 produced the lowest IC₅₀ value among all groups (17.97 μM). Both combinations showed synergistic interactions in cell viability response particularly at moderate effect levels. FOLFOX +2 consistently reduced wound closure in both cellular models. Gene expression analyses revealed target- and cell model-dependent modulation of drug transporter-, stemness-, and migration/metastasis-associated genes rather than uniform suppression. Docking analyses supported the predicted interaction potential of compounds 1 and 2 with multiple cancer-related targets. Overall, these findings suggest that isoeugenol-derived polyphenolic compounds may modulate FOLFOX-associated responses through cell viability-related, migration-related, multidrug resistance-associated, and stemness-linked mechanisms.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tokat Gaziosmanpasa University, Tokat, Türkiye. Electronic address: nsema.bilgin@gmail.com.
- Department of Forestry, Almus Vocational School, Tokat Gaziosmanpasa University, Tokat, Türkiye.
- Department of Biostatistics and Medical Informatics, Faculty of Medicine, Inönü University, Malatya, Türkiye.
- Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tokat Gaziosmanpasa University, Tokat, Türkiye.
- Department of Health Services, Vocational School of Higher Education for Healthcare Services, Igdır University, Igdır, Türkiye.
- Department of Chemistry, Faculty of Arts and Sciences, Tokat Gaziosmanpasa University, Tokat, Türkiye.
Förderung
- TÜBİTAK
Zitieren
APA
Bilgin, S., Tayhan, Y., Yaşar, Ş., Erden Tayhan, S., Yıldırım Kocaman, A., & Koç, E. (2026). Isoeugenol-derived polyphenolic compounds modulate FOLFOX response, drug resistance, migration, and stemness-associated signatures in HT29 colon cancer cells and an HT29-CSC-enriched population. Bioorganic Chemistry, 185, 110714. https://doi.org/10.1016/j.bioorg.2026.110714
Vancouver
Bilgin S, Tayhan Y, Yaşar Ş, Erden Tayhan S, Yıldırım Kocaman A, Koç E. Isoeugenol-derived polyphenolic compounds modulate FOLFOX response, drug resistance, migration, and stemness-associated signatures in HT29 colon cancer cells and an HT29-CSC-enriched population. Bioorganic Chemistry. 2026;185:110714. doi:10.1016/j.bioorg.2026.110714
BibTeX
@article{Bilgin2026,
author = {Bilgin, Sema and Tayhan, Yahya and Yaşar, Şeyma and Erden Tayhan, Seçil and Yıldırım Kocaman, Aslı and Koç, Esra},
title = {Isoeugenol-derived polyphenolic compounds modulate FOLFOX response, drug resistance, migration, and stemness-associated signatures in HT29 colon cancer cells and an HT29-CSC-enriched population},
journal = {Bioorganic Chemistry},
year = {2026},
volume = {185},
pages = {110714},
doi = {10.1016/j.bioorg.2026.110714}
}
EUVIMED